Improved interpretation and clinical validation of substitutions in HIV-1 protease predicting the virological response to darunavir/ritonavir

被引：0
|
作者：
De Luca, A. [1 ]
Di Giambenedetto, S. [1 ]
Marando, F. [2 ]
Maserati, R. [3 ]
Gianotti, N. [4 ]
Narciso, P. [5 ]
Antinori, A. [5 ]
Di Perri, G. [6 ]
Baldanti, F. [3 ]
Zazzi, M. [7 ]
Perno, C. F. [2 ]
Santoro, M. M. [2 ]
机构：
[1] Catholic Univ, Rome, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
[3] Policlin San Matteo IRCCS, Pavia, Italy
[4] Hosp San Raffaele, I-20132 Milan, Italy
[5] IRCCS, Natl Inst Infect Dis L Spallanzani, Rome, Italy
[6] Univ Turin, Turin, Italy
[7] Univ Siena, I-53100 Siena, Italy
来源：
ANTIVIRAL THERAPY | 2008年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：A104 / A104
页数：1
相关论文
共 50 条
  • [1] Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new score
    De Luca, Andrea
    Di Giambenedetto, Simona
    Maserati, Renato
    Gianotti, Nicola
    Narciso, Pasquale
    Antinori, Andrea
    Di Perri, Giovanni
    Prosperi, Mattia C. F.
    Baldanti, Fausto
    Micheli, Valeria
    Zazzi, Maurizio
    Perno, Carlo F.
    Santoro, Maria M.
    ANTIVIRAL THERAPY, 2011, 16 (04) : 489 - 497
  • [2] Positive Impact of HIV-1 gag Cleavage Site Mutations on the Virological Response to Darunavir Boosted with Ritonavir
    Larrouy, Lucile
    Lambert-Niclot, Sidonie
    Charpentier, Charlotte
    Fourati, Slim
    Visseaux, Benoit
    Soulie, Cathia
    Wirden, Marc
    Katlama, Christine
    Yeni, Patrick
    Brun-Vezinet, Francoise
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    Descamps, Diane
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (04) : 1754 - 1757
  • [3] Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patients
    Descamps, Diane
    Lambert-Niclot, Sidonie
    Marcelin, Anne-Genevieve
    Peytavin, Gilles
    Roquebert, Benedicte
    Katlama, Christine
    Yeni, Patrick
    Felices, Mathieu
    Calvez, Vincent
    Brun-Vezinet, Francoise
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (03) : 585 - 592
  • [4] DRUG RESISTANCE PROFILES OF HIV-1 POSITIVE PATIENTS EXPERIENCING VIROLOGICAL REBOUND ON RITONAVIR-BOOSTED DARUNAVIR MONOTHERAPY
    Abdullahi, A.
    Fopoussi, O. M.
    Beloukas, A.
    Defo, V. F.
    Moudourou, S.
    Kouanfack, C.
    Torimiro, J.
    Geretti, A. M.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2019, 113 : S211 - S212
  • [5] Mutational patterns and correlated amino acid substitutions in the HIV-1 protease after virological failure to nelfinavir- and lopinavir/ritonavir-based treatments
    Garriga, Cesar
    Perez-Elias, Maria Jesus
    Delgado, Rafael
    Ruiz, Lidia
    Najera, Rafael
    Pumarola, Tomas
    Alonso-Socas, Maria del Mar
    Garcia-Bujalance, Silvia
    Menendez-Arias, Luis
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (11) : 1617 - 1628
  • [6] Predictive value of HIV-1 protease genotype and virtual phenotype on the virological response to lopinavir/ritonavir-containing salvage regimens
    Loutfy, MR
    Raboud, JM
    Walmsey, SL
    Saskin, R
    Montaner, JS
    Hogg, RS
    Thompson, CA
    Harrigan, PR
    ANTIVIRAL THERAPY, 2004, 9 (04) : 595 - 602
  • [7] HIV-1 protease, Gag and gp41 baseline substitutions associated with virological response to a PI-based regimen
    Perrier, Marine
    Castain, Louise
    Regad, Leslie
    Todesco, Eve
    Landman, Roland
    Visseaux, Benoit
    Yazdanpanah, Yazdan
    Rodriguez, Christophe
    Joly, Veronique
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    Descamps, Diane
    Charpentier, Charlotte
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (06) : 1679 - 1692
  • [8] Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment
    Barragan, Patricia
    Podzamczer, Daniel
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (13) : 2363 - 2375
  • [9] How Does Darunavir Prevent HIV-1 Protease Dimerization?
    Huang, Danzhi
    Caflisch, Amedeo
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2012, 8 (05) : 1786 - 1794
  • [10] The higher barrier of darunavir and tipranavir resistance for HIV-1 protease
    Wang, Yong
    Liu, Zhigang
    Brunzelle, Joseph S.
    Kovari, Iulia A.
    Dewdney, Tamaria G.
    Reiter, Samuel J.
    Kovari, Ladislau C.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 412 (04) : 737 - 742
12345